Pharma Stocks In India: Sun Pharmaceutical Industries, Lupin, and other Indian pharma stocks were trading with deep cuts after US President Donald Trump announced a steep 100% tariff on branded and patented pharmaceutical imports starting October 1, 2025—unless the company is building a manufacturing facility in the United States.

In a post on Truth Social, Trump clarified that the tariffs would not apply to pharmaceutical products if the company has already begun construction on a U.S. manufacturing plant.

“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. ‘IS BUILDING’ will be defined as, ‘breaking ground’ and/or ‘under construction.’ There w

See Full Page